Clinical Trials Logo

Filter by:
NCT ID: NCT03045406 Active, not recruiting - Clinical trials for Venous Thromboembolism

Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer

CARAVAGGIO
Start date: April 13, 2017
Phase: Phase 3
Study type: Interventional

Apixaban for the treatment of venous thromboembolism in patients with cancer: a prospective randomized open blinded end-point (PROBE) study

NCT ID: NCT03044093 Recruiting - Clinical trials for Second Trimester Abortion

Mifepristone and Misoprostol Compared With Misoprostol Alone for Second Trimester Abortion

Start date: January 2017
Phase: Phase 4
Study type: Interventional

Mifepristone and Misoprostol Compared With Misoprostol Alone for Second Trimester Abortion - a Double Blinded Randomized Controlled Trial

NCT ID: NCT03043872 Active, not recruiting - Clinical trials for Small Cell Lung Carcinoma Extensive Disease

Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)

CASPIAN
Start date: March 27, 2017
Phase: Phase 3
Study type: Interventional

This is a phase III, randomized, open-label, multicenter, global study to determine the efficacy and safety of combining durvalumab ± tremelimumab with platinum based chemotherapy (EP) followed by durvalumab ± tremelimumab maintenance therapy versus EP alone as first-line treatment in patients with extensive-stage small-cell lung cancer

NCT ID: NCT03042130 Withdrawn - Heart Failure Clinical Trials

Treatment With IV Iron in Hospitalized Patients With Severe Heart Failure But Without Iron Deficiency

Start date: December 14, 2016
Phase: Phase 4
Study type: Interventional

Patients with congestive heart failure, grade 3-4, in addition to the standard care, will be randomized 1:1. The study group will receive 2 doses of IV iron (Iron carboxymaltose). The control group will receive standard of care alone. The study will test for the effects of the additional IV iron on the symptoms, clinical picture and quality of life of the treated patients.

NCT ID: NCT03041922 Recruiting - Clinical trials for Changes in Elasticity Duo to Pressure Ulcers in Buttocks

Estimation of Changes in Soft Tissue Rigidity of the Buttocks in Sitting Under Weight Bearing Compared to Sitting Without Weight Bearing

Start date: March 1, 2017
Phase: N/A
Study type: Observational [Patient Registry]

Estimation of Changes in Soft Tissues Elasticity in Buttocks in lying down and sitting positions by using ultrasound device. the elasticity of fat and muscle tissues will be measured. May ultrasound exam helps to predict the development of pressure ulcers in buttocks due to continuous sitting.

NCT ID: NCT03041246 Completed - Clinical trials for Pelvic Floor Disorders

Manual Fascial Manipulation in Pregnant Women

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Pregnancy and vaginal delivery are considered as the main risk factors for damage to the pelvic floor. There are various ways to measure the strength of the pelvic floor and to evaluate functional problems. Manual mobilization of the pelvic floor is a well-known treatment modality, however, ample knowledge exists on the efficacy of physiotherapy and exercise for improvement of pelvic floor function and strength. The aim of this study is to analyze the influence of pelvic floor fascial mobilization (PFFM) technique on the function and strength of the pelvic floor muscles as well as parameters presumed to be influenced by the strength of the pelvic floor in pregnant women.

NCT ID: NCT03040999 Active, not recruiting - Clinical trials for Head and Neck Neoplasms

Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)

Start date: April 5, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the efficacy and safety of pembrolizumab given concomitantly with chemoradiation (CRT) and as maintenance therapy versus placebo plus CRT in participants with locally advanced head and neck squamous cell carcinoma (LA HNSCC). The primary hypothesis is that pembrolizumab in combination with CRT is superior to placebo in combination with CRT with respect to event-free survival (EFS).

NCT ID: NCT03040856 Withdrawn - Clinical trials for Omega 3 Supplements During Pregnancy

The Effect of Alpha Linolenic Acid (ALA) Supplementation During Pregnancy

Start date: February 1, 2022
Phase: N/A
Study type: Interventional

Omega-3 fatty acids are "good fats," and are among the most important nutrients lacking in Western diets today. The average person in developing countries consumes less than 100 mg of DHA daily. With increasing awareness of the importance of DHA, many people realize that they need to make a change in their diet by adding DHA-rich foods or supplements. The aim of this study is to learn the effect of different supplementations from the omega 3 group on the maternal and fetal fatty acid profile during pregnancy and to study their epigenetic influence.

NCT ID: NCT03040414 Completed - Clinical trials for Type 1 Diabetes Mellitus

Fuzzy Logic Automated Insulin Regulation

FLAIR
Start date: June 3, 2019
Phase: N/A
Study type: Interventional

Adolescents and young adults with type 1 diabetes often have a difficult time achieving good glucose control, which is so important in reducing the risk for diabetes complications. Despite the use of multiple daily injections or insulin pumps and glucose sensors, there is still a need for many individuals to further improve glucose levels without causing low blood glucose levels (hypoglycemia) or adding to the daily burden of living with diabetes. Today an insulin pump can receive glucose readings from a continuous glucose monitor and adjust the insulin delivery in an attempt to keep glucose levels in a more optimal range. These systems are called hybrid closed loop (HCL). This means that much of the insulin delivery is automated, yet the patient still interacts regularly with the system, particularly to help determine the insulin dose to deliver to cover a meal. Results of early studies using HCL systems in adolescents and adults with type 1 diabetes are encouraging. The objective of this study is to compare the efficacy and safety of the automated insulin delivery (AID) system with proportional integral-derivative (PID) algorithm (Minimed 670G 3.0 HCL) to an AID system with combined PID and Fuzzy Logic Algorithm (Minimed 670G 4.0 Advanced Hybrid Closed-Loop (AHCL)). The trial will test the hypothesis that the Minimed AHCL can reduce daytime hyperglycemia, currently the biggest challenge for AID systems, without increasing hypoglycemia. Up to 124 adolescents and young adults (ages 14-<30) will be recruited to test each system for three months in a randomized crossover trial. Investigators will compare how effective each hybrid closed loop system is at preventing high blood glucose readings during the day. The investigators will also evaluate the safety of each system and how participants adjust to the daily use of the technology.

NCT ID: NCT03039855 Active, not recruiting - Clinical trials for Mitral Valve Regurgitation

Tiaraâ„¢ Transcatheter Mitral Valve Replacement Study

TIARA-II
Start date: January 2017
Phase: N/A
Study type: Interventional

To evaluate the safety and performance of the Neovasc Tiara Mitral Transcatheter Heart Valve with the Tiara Transapical Delivery System.